Track the 유한양행 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 유한양행 has logged 108 insider filings. Market capitalisation: €5,151.2bn. The latest transaction was reported on 2 July 2026 (Other). Among the most active insiders: 김열홍. All data is openly available.
108
Insider Decl.
0
Thresholds
€195m
76 ops.
Buy Volume
·
7 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 유한양행 Buy (bullish), based on 18 analysts. Average price target: ₩129,222.
33Σ signal
Buys €195m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 14,068 of 26,179 companies
49.8
score / 100
Value
40
Quality
60
FCF yld-0.8%
Earn yld3.8%
EV/EBITDA17.8x
ROE8.9%
Gross mgn33%
Net mgn8.9%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
300 shares@ ₩91,967.000.0000% mcap100.0% of flowShareKRXDART:20260413001715
Ideal exit: 4 Jan 2027 (T+270)
25 of 108 declarations
About 유한양행
Yuhan Corporation is a South Korean pharmaceutical company engaged in the research, development, and manufacturing of drugs. It is listed on the Korea Exchange, XKRX.
